Can drug price hikes via debranding be prevented?

Steep price hikes following the debranding of off‐patent medicines are becoming increasingly common in the UK, adding hundreds of millions to the NHS drugs bill. But can anything be done to prevent this?

Source: Prescriber - May 2, 2017 Category: Primary Care Authors: Farasat Bokhari, Bruce Lyons Tags: Drug Pricing Source Type: research